Omnicare Inc

Omnicare — Credit Suisse conference (November 2014)

21 slides from Omnicare's conference presentation, Nov 10, 2014

  1. Slide 1: Omnicare

    Slide 1: Omnicare

    Omnicare

  2. Slide 2: Forward-Looking Statements

    Slide 2: Forward-Looking Statements

    Forward-Looking Statements Certain of the statements made today and listed within ji ion slides are f rd-looki ‘statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-| looking statements include, but: are not limited to, all statements regarding the int

  3. Slide 3: Agenda

    Slide 3: Agenda

    Agenda Long-Term Care Pharmacy | Multi-Layered Growth Strategy

  4. Slide 4: Omnicare Background

    Slide 4: Omnicare Background

    1} Omnicare Background

  5. Slide 5: Company Journey: Significant Transformation Underway

    Slide 5: Company Journey: Significant Transformation Underway

    Company Journey Significant Transformation Underway mation of LTC assessment, LTC operations, account Specialty Care Group operational evaluation management restructure SCG sales strategy Centralization strategy for developed; sales team certain key operating and support functions 2011 Evaluation of

  6. Slide 6: Company Journey: Transition to an Integrated Operating Entity

    Slide 6: Company Journey: Transition to an Integrated Operating Entity

    Company Journey Transition to an Integrated Operating Entity Y _ y 5 3Y) Omnicare 39} Onmicare Qminicare 7? Accumted Long-Term Perms Specialty Care Group Care Group) Omnicar jal Research ACS 3 illed Brand (Saeed eer Nursing Support Supply Chala Tidewater Pharmacy ices 3 om tt > 4 FGrossroads » rosar

  7. Slide 7: Omnicare's Primary Businesses

    Slide 7: Omnicare's Primary Businesses

    Omnicare’s Primary Businesses Six Platforms, One Common Value Proposition Long-Term Care Group Specialty Care Group Brand Support Supply Chain Services Platforms Skilled Nursing —_ Assisted Living Solutions Pharmacy Pharmacy Patient Support — Services Pharmacy Customers _ Skilled nursing, assisted l

  8. Slide 8: Company Journey: Business Mix Reflects More Diversification

    Slide 8: Company Journey: Business Mix Reflects More Diversification

    Company Journey Business Mix Reflects More Diversification 2010 Revenue Mix 2014 Revenue Mix" Long-Term Care = Specialty Care Long-Term Care = Specialty Care Rapid growth within our Specialty Care Group has accelerated our objective of becoming a diversified healthcare service provider 1, Data for 1

  9. Slide 9: Financial Results: Quarter Trends

    Slide 9: Financial Results: Quarter Trends

    Financial Results) Quarter Trends Revenue Adjusted EBITDA 4a13 1014 2014 a4 4013 1014 2014 3014 Adjusted Cash EPS Cumulative Cash Flow from Operations M soe enn 97.5% of CFFO Returned to Shareholders $0.92 $0.88 | $0.80 | 4013 1014 2014 3014 4013 1014 2014 3014 Omnicare

  10. Slide 10: Long-Term Care Pharmacy

    Slide 10: Long-Term Care Pharmacy

    (2) Long-Term Care Pharmacy;

  11. Slide 11: Long-Term Care at a Glance

    Slide 11: Long-Term Care at a Glance

    Long-Term Care at a Glance Nationwide footprint focused on lowering Efficient Operations that utilizes proprietary overall healthcare costs and improving health automation; which reduces costs while outcomes for patients improving accuracy and consistency of service Robust clinical Infrastructure su

  12. Slide 12: Market Dynamics - Long-Term Care: Aging Population

    Slide 12: Market Dynamics - Long-Term Care: Aging Population

    Market Dynamics - Long-Term Care Aging Population Shaping US Healthcare System") Aged 85+ CAGR Aged 65 - 84 410,000,000 mUnder 65 370,000,000 330,000,000 290,000,000 250,000,000 2012 2016 2020 2024 2028 2032 2036 2040 2044 2048 2052 2056 2060 Seniors’ utilization of pharmaceuticals is more than thre

  13. Slide 13: Market Dynamics - Long-Term Care: Generic Volumes

    Slide 13: Market Dynamics - Long-Term Care: Generic Volumes

    Market Dynamics - Long-Term Care Generic Volumes Expected to Continue to Increase 88% 86% 82% 2012 2013 2014E 2015E 2016E Increase in the generic dispensing rate is a key driver for Omnicare because low cost generic drug introductions benefit the company, its customers, and payers E poland i 32 omni

  14. Slide 14: Specialty Care Group

    Slide 14: Specialty Care Group

    (3) Specialty Care Group

  15. Slide 15: Specialty Care Group at a Glance

    Slide 15: Specialty Care Group at a Glance

    Specialty Care Group at a Glance Value Propositi Manufacturer partner programs providing Dedicated clinical specialists manage customized integrated solutions programs that improve access to therapy Coordination and adherence programs reduce Enh d id costs and lead to improved patient outcomes suppo

  16. Slide 16: Specialty Market Overview

    Slide 16: Specialty Market Overview

    1. 2013 Expr Specialty Market Overview 2014 to 2016 Expected Three Year Compound Growth") Cancer Growth Deficiency Hepatitis © HIV Inflammatory Conditions Miscellaneous CNS Disorders Muttiple Sclerosis, Pulmonary Hypertension = Q EOS spi Transplant Total Specialty 100% U.S. speci | @% 0% 100% 200% 3

  17. Slide 17: Growth in Specialty Market

    Slide 17: Growth in Specialty Market

    Growth in Specialty Market Specialty products expected to account for 41% of USA sales by 20201) Share of USA Biotechnology Sales 2006 2020 Biotech Biotech = Conventior cr ic 8Cor Within the top 100 prescription products, biologics have seen a rapid increase in share from 21% in 2006 to an expected

  18. Slide 18: Multi-Layered Growth Strategy

    Slide 18: Multi-Layered Growth Strategy

    (4) Multi-Layered Growth Strategy

  19. Slide 19: Multi-Layered Growth Strategy

    Slide 19: Multi-Layered Growth Strategy

    Multi-Layered Growth Strategy Key Components to 2015 Growth Objectives Capture share in SNF; capitalize on Saremelinits adjacent markets LTC operation ong-Term Care market growth enhancements ae (e.g., MRDD, PACE) Capitalize on strong , ; ; alize oni3| Innovative model Robust specialty Specialty Car

  20. Slide 20: Value Creation

    Slide 20: Value Creation

    Value Creation Drivers to Increasing Value Leading Market Position Strong Cash Flow Capabilities / Capital Deployment Strategies Sourcing Optimization Strategy

  21. Slide 21: Omnicare

    Slide 21: Omnicare

    Omnicare

Source: SEC EDGAR · 8-K filed Nov 10, 2014

More decks from Omnicare Inc